Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots-Reference-Cited by-同舟云学术

Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots

Published:2023-01-10 Issue:3 Volume:8 Page:3319-3328
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Gillespie Paul F.¹^ORCID,Wang Yanjie¹,Hofmann Carl¹,Kuczynski Laura E.²,Winters Michael A.²,Teyral Jennifer L.³,Tubbs Christopher M.¹,Shiflett Kelsey¹,Patel Nisarg¹,Rustandi Richard R.¹

Affiliation:

1. Analytical Research Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States

2. Vaccine Process Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States

3. Research CMC Statistics, Merck & Co., Inc., 770 Sumneytown Pike, West Point, Pennsylvania19486, United States

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c06937

Reference36 articles.

1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (accessed 04 March, 2022).

2. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

3. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

4. A Genomic Perspective on the Origin and Emergence of SARS-CoV-2

5. Characteristics of SARS-CoV-2 and COVID-19

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enabling functionality and translation fidelity characterization of mRNA-based vaccines with a platform-based, antibody-free mass spectrometry detection approach;2024-05-14

2. Development and qualification of an automated capillary Western method for the identification of polysaccharide serotypes in pneumococcal conjugate vaccine (PCV);Journal of Pharmaceutical and Biomedical Analysis;2024-01

3. Challenges and Opportunities in the Process Development of Chimeric Vaccines;Vaccines;2023-12-08

4. Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS‐CoV‐2;Biotechnology Journal;2023-10-10